Mark J. Eliason

First-in-human Mutation-targeted siRNA Phase Ib Trial of an Inherited Skin Disorder

Sancy A. Leachman, Robyn P. Hickerson, Mary Schwartz et al. · Molecular Therapy · 2009 · 261 citations · Full text

Life Sciences, Dermatology, Molecular Biology +12

Effect of a rapid response system for patients in shock on time to treatment and mortality during 5 years*

Frank Sebat, Amjad A. Musthafa, David Johnson et al. · Critical Care Medicine · 2007 · 201 citations

Health Professions, Health Services Administration, Emergency Management +12

Population-Based Prevalence of CDKN2A Mutations in Utah Melanoma Families

Mark J. Eliason, April A. Larson, Scott R. Florell et al. · Journal of Investigative Dermatology · 2006 · 61 citations

Medicine, Genetics, Oncology +16

Administrative Burden and Costs of Prior Authorizations in a Dermatology Department

Ryan Carlisle, Nicholas D. Flint, Zachary Hopkins et al. · JAMA Dermatology · 2020 · 53 citations · Full text

Pharmacy, Dermatology, Health Services Administration +17

Treatment of chronic urticaria with colchicine.

Lana N. Pho, Mark J. Eliason, Michelle Regruto et al. · PubMed · 2011 · 37 citations

Life Sciences, Dermatology, Pharmacotherapy +9